# The Effect of Omeprazole on the Pharmacokinetics of Dasatinib in Healthy Subjects

> **NCT00655746** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 14 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Dasatinib + Omeprazole

## Key facts

- **NCT ID:** NCT00655746
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2009-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00655746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00655746, "The Effect of Omeprazole on the Pharmacokinetics of Dasatinib in Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00655746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*